BACKGROUND: Improving strategies for risk reduction among family members of patients with melanoma may reduce their risk for melanoma. OBJECTIVE: To evaluate the effects of two behavioral interventions designed to improve the frequency of total cutaneous skin examination by a health provider (TCE), skin self-examination (SSE), and sun protection among first degree relatives of patients with melanoma; and to evaluate whether increased intentions, increased benefits, decreased barriers, and improved sunscreen self-efficacy mediated the effects of the tailored intervention, as compared with the generic intervention on TCE, SSE, or sun protection. METHODS:Four hundred forty-three family members (56 parents, 248 siblings, 239 children) who were nonadherent with these practices were randomly assigned to either a generic (N = 218) or a tailored intervention (N = 225) which included 3 print mailings and 1 telephone session. Participants completed measures of TCE, SSE, and sun protections at baseline, 6 months, and 1 year, and measures of intentions, benefits, barriers, and self-efficacy at baseline and 6 months. RESULTS: Those enrolled in the tailored intervention had almost a twofold increased probability of having a TCE ( p < .0001). Treatment effects in favor of the tailored intervention were also noted for sun protection habits ( p < .02). Increases in TCE intentions mediated the tailored intervention's effects on TCE. Increases in sun protection intentions mediated effects of the tailored intervention's effect on sun protection. CONCLUSIONS: Tailored interventions may improve risk reduction practices among family members of patients with melanoma.
RCT Entities:
BACKGROUND: Improving strategies for risk reduction among family members of patients with melanoma may reduce their risk for melanoma. OBJECTIVE: To evaluate the effects of two behavioral interventions designed to improve the frequency of total cutaneous skin examination by a health provider (TCE), skin self-examination (SSE), and sun protection among first degree relatives of patients with melanoma; and to evaluate whether increased intentions, increased benefits, decreased barriers, and improved sunscreen self-efficacy mediated the effects of the tailored intervention, as compared with the generic intervention on TCE, SSE, or sun protection. METHODS: Four hundred forty-three family members (56 parents, 248 siblings, 239 children) who were nonadherent with these practices were randomly assigned to either a generic (N = 218) or a tailored intervention (N = 225) which included 3 print mailings and 1 telephone session. Participants completed measures of TCE, SSE, and sun protections at baseline, 6 months, and 1 year, and measures of intentions, benefits, barriers, and self-efficacy at baseline and 6 months. RESULTS: Those enrolled in the tailored intervention had almost a twofold increased probability of having a TCE ( p < .0001). Treatment effects in favor of the tailored intervention were also noted for sun protection habits ( p < .02). Increases in TCE intentions mediated the tailored intervention's effects on TCE. Increases in sun protection intentions mediated effects of the tailored intervention's effect on sun protection. CONCLUSIONS: Tailored interventions may improve risk reduction practices among family members of patients with melanoma.
Authors: H L Howe; P A Wingo; M J Thun; L A Ries; H M Rosenberg; E G Feigal; B K Edwards Journal: J Natl Cancer Inst Date: 2001-06-06 Impact factor: 13.506
Authors: Thomas R Fears; Cameron C Bird; DuPont Guerry; Richard W Sagebiel; Mitchell H Gail; David E Elder; Allan Halpern; Elizabeth A Holly; Patricia Hartge; Margaret A Tucker Journal: Cancer Res Date: 2002-07-15 Impact factor: 12.701
Authors: Elyse Shuk; Jack E Burkhalter; Carlos F Baguer; Susan M Holland; Alisa Pinkhasik; Mary Sue Brady; Daniel G Coit; Charlotte E Ariyan; Jennifer L Hay Journal: Qual Health Res Date: 2012-07
Authors: Anita Y Kinney; Rachel Howell; Rachel Ruckman; Jean A McDougall; Tawny W Boyce; Belinda Vicuña; Ji-Hyun Lee; Dolores D Guest; Randi Rycroft; Patricia A Valverde; Kristina M Gallegos; Angela Meisner; Charles L Wiggins; Antoinette Stroup; Lisa E Paddock; Scott T Walters Journal: Contemp Clin Trials Date: 2018-09-18 Impact factor: 2.226
Authors: Jerod L Stapleton; Kristina L Tatum; Katie A Devine; Sue Stephens; Margaret Masterson; Amna Baig; Shawna V Hudson; Elliot J Coups Journal: Pediatr Blood Cancer Date: 2015-10-29 Impact factor: 3.167
Authors: Alan C Geller; Barbra A Dickerman; Jennifer M Taber; Laura A Dwyer; Anne M Hartman; Frank M Perna Journal: Prev Med Date: 2018-02-06 Impact factor: 4.018
Authors: Ellen R Gritz; Mary K Tripp; Susan K Peterson; Alexander V Prokhorov; Sanjay S Shete; Diana L Urbauer; Bryan M Fellman; Jeffrey E Lee; Jeffrey E Gershenwald Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-10 Impact factor: 4.254